© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
July 01, 2015
This prospective epidemiological study compares the capabilities of the new 2013 American Heart Association and American College of Cardiology ASCVD risk calculator against several alternative cardiovascular risk calculators and explores the potential effect of preventive therapy on risk overestimation in the AHA-ACC-ASCVD model.
AI Algorithm May Help Identify Eligibility for Diabetic Retinopathy Clinical Trials
Caroline Baumal, MD: The Promising Durability of Faricimab for DME
Bevacizumab Linked to Greater ROP Retreatment than Ranibizumab